Trifluoperazine Tablets IP 5 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Trifluoperazine Tablets IP 5 mg | Manufacturer
Product image for Trifluoperazine Tablets IP 5 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Trifluoperazine |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Antipsychotic drugs |
| Subcategory | Antipsychotic drugs |
| Active Ingredient | Trifluoperazine |
| Strength | 5 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antipsychotic drugs |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Trifluoperazine Tablets IP 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Acute and maintenance treatment of schizophrenia and related psychotic disorders. 2. Bipolar I disorder mania, mood stabilization, and severe behavioral agitation. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Trifluoperazine Tablets IP 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Trifluoperazine Tablets IP 5 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Trifluoperazine Tablets IP 5 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Trifluoperazine Tablets IP 5 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally once or twice daily, with or without food. Titrate gradually from a low initial dose under close psychiatric supervision. Do not discontinue therapy abruptly. | ||||||||||||||||||||||||
| Side Effects | Common: Somnolence, sedation, dry mouth, weight gain, constipation, mild dizziness. Uncommon: Extrapyramidal symptoms, orthostatic hypotension, akathisia, elevated prolactin. Rare: Neuroleptic malignant syndrome, tardive dyskinesia, agranulocytosis (with clozapine). | ||||||||||||||||||||||||
| Warnings and Precautions | Metabolic Monitoring: Regularly check fasting blood glucose, lipid profiles, and body weight. Hematologic & ECG Monitoring: Periodic complete blood counts and ECGs are indicated during chronic therapy. Sedation & Driving: Avoid driving or operating machinery until individual tolerance is established. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Trifluoperazine or related psychotropic derivatives. 2. Severe central nervous system depression, comatose states, or severe bone marrow suppression. 3. Uncontrolled epilepsy or history of severe blood dyscrasias. | ||||||||||||||||||||||||
| Drug Interactions | 1. CNS Depressants & Alcohol: Potentiated sedation, psychomotor slowing, and respiratory depression. 2. Antihypertensives: Synergistic orthostatic hypotensive effects. 3. CYP Enzymes: Inhibitors (fluoxetine, ketoconazole) increase antipsychotic levels; inducers decrease efficacy. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Trifluoperazine Tablets IP 5 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Trifluoperazine Tablets IP 5 mg? | The source specification is IP; confirm the required standard before contracting. |
| What quality tests are applicable for Trifluoperazine Tablets IP 5 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Trifluoperazine Tablets IP 5 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Trifluoperazine Tablets IP 5 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Trifluoperazine Tablets BP 5 mg ExporterView product →
✚
Trifluoperazine Tablets BP 5 mg ManufacturerView product →
✚
Trifluoperazine Tablets BP 5 mg SupplierView product →
✚
Trifluoperazine Tablets IP 5 mg ExporterView product →
✚
Trifluoperazine Tablets IP 5 mg SupplierView product →
✚
Chlorpromazine Hydrochloride Tablets IP 100 mg ExporterView product →
✚
Chlorpromazine Hydrochloride Tablets IP 100 mg ManufacturerView product →
✚
Chlorpromazine Hydrochloride Tablets IP 100 mg SupplierView product →
✚
Chlorpromazine Hydrochloride Tablets IP 25 mg ExporterView product →
✚
Chlorpromazine Hydrochloride Tablets IP 25 mg ManufacturerView product →
✚
Chlorpromazine Hydrochloride Tablets IP 25 mg SupplierView product →
✚
Chlorpromazine Hydrochloride Tablets USP 25 mg ExporterView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →